Read more Scholtes et al., European Urology Open Science, 2026

21 October 2026

Publication of our study showing that among bladder cancer patients with available clinical outcomes after platinum-based chemotherapy, ex vivo chemosensitivity scores significantly distinguished responders from non-responders.

Read more

Read more Koedoot et al., npj Precision Oncology, 2025

30 August 2025

Publication of our study showing that VitroScan's 3D ex vivo micro-tumor testing platform can accurately predict whether an ovarian cancer patient will respond to chemotherapy.

Read more